Cargando…

Significant decrease in plasmad‐dimer levels and mean platelet volume after a 3‐month treatment with rosuvastatin in patients with venous thromboembolism

BACKGROUND: Inflammation has been considered as a possible mechanism for the initiation and recurrence of venous thromboembolism (VTE). Statins have anti‐inflammatory and potential immune‐modulatory effects, but their effect on plasmad‐dimer levels is controversial. HYPOTHESIS: In this study, we aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alirezaei, Toktam, Sattari, Haniyeh, Irilouzadian, Rana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286331/ https://www.ncbi.nlm.nih.gov/pubmed/35481712 http://dx.doi.org/10.1002/clc.23833

Ejemplares similares

Response: Comment on “Significant decrease in plasma D‐dimer levels and mean platelet volume after a 3‐month treatment with rosuvastatin in patients with venous thromboembolism”
por: Alirezaei, Toktam, et al.
Publicado: (2022)

Comment on “significant decrease in plasma d‐dimer levels and mean platelet volume after a 3‐month treatment with rosuvastatin in patients with venous thromboembolism”
por: Coban, Erkan
Publicado: (2022)

CHA(2)DS(2)‐VASc and PESI scores are associated with right ventricular dysfunction on computed tomography pulmonary angiography in patients with acute pulmonary thromboembolism
por: Alirezaei, Toktam, et al.
Publicado: (2022)

Accidental and Late Diagnosis of Type A Aortic Dissection: Mimicking Unstable Angina Pectoris
por: Alirezaei, Toktam, et al.
Publicado: (2022)

Fatal association of COVID‐19 and acute type A aortic dissection
por: Irilouzadian, Rana, et al.
Publicado: (2022)

Novel Anthropometric Indices as Screening Tools for Obesity: A Study on Healthy Iranians
por: Alirezaei, Toktam, et al.
Publicado: (2023)

Intramural Esophageal Hematoma Mimicking Acute Coronary Syndrome: Complication of Warfarin Use in a Mechanical Heart Valve Patient
por: Alirezaei, Toktam, et al.
Publicado: (2022)

Elevated Cardiac Troponin I following Asymptomatic Intradialytic Hypotension: A Pilot Study with a 2-Year Follow-Up
por: Alirezaei, Toktam, et al.
Publicado: (2022)

Marijuana-induced myocarditis in a 24-year-old man
por: Alirezaei, Toktam, et al.
Publicado: (2022)

The role of blood urea nitrogen to serum albumin ratio in the prediction of severity and 30‐day mortality in patients with COVID‐19
por: Alirezaei, Toktam, et al.
Publicado: (2022)

25-Hydroxy Vitamin D Level and Its Correlation with Mean Platelet Volume in Preeclampsia
por: Alirezaei, Toktam, et al.
Publicado: (2022)

Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism
por: Said, Karim
Publicado: (2013)

A rare presentation of pulmonary thromboembolism as seizure
por: Alirezaei, Toktam, et al.
Publicado: (2022)

Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study
por: Zheng, Huaguang, et al.
Publicado: (2022)

Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma
por: Rupa-Matysek, Joanna, et al.
Publicado: (2018)

The role of neutrophil‐lymphocyte ratio, and mean platelet volume in detecting patients with acute venous thromboembolism
por: Farah, Raymond, et al.
Publicado: (2019)

Lymphocytes, Mean Platelet Volume, and Albumin in Critically Ill COVID-19 Patients with Venous Thromboembolism
por: Duan, Rundan, et al.
Publicado: (2023)

Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI
por: Khorana, Alok A., et al.
Publicado: (2022)

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
por: Orsi, Fernanda A., et al.
Publicado: (2019)

Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
por: Choi, JungMin, et al.
Publicado: (2021)

Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases
por: Heestermans, Marco, et al.
Publicado: (2022)

Addition of aspirin to venous thromboembolism chemoprophylaxis safely decreases venous thromboembolism rates in trauma patients
por: Lammers, Daniel, et al.
Publicado: (2023)

Effectiveness of D-Dimer as a Screening Test for Venous Thromboembolism: An Update
por: Pulivarthi, Swaroopa, et al.
Publicado: (2014)

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
por: Jung, Hae Won, et al.
Publicado: (2023)

Cost‐minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D‐dimer for exclusion of venous thromboembolism
por: Verma, Karan, et al.
Publicado: (2017)

Effects of perioperative rosuvastatin on postoperative delirium in elderly patients: A randomized, double-blind, and placebo-controlled trial
por: Xu, Xiao-Qin, et al.
Publicado: (2021)

The value of blood D-dimer test in the diagnosis of walk-in patients with venous thromboembolism
por: Yasuoka, Shozo, et al.
Publicado: (2011)

Novel screening criteria for post‐traumatic venous thromboembolism by using D‐dimer
por: Iyama, Keita, et al.
Publicado: (2018)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

Clinical Utility of D-Dimer for Rule-Out or Rule-In of Venous Thromboembolism in Syncope
por: Badertscher, Patrick, et al.
Publicado: (2022)

Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies
por: Robinson, Jennifer G., et al.
Publicado: (2014)

Accuracy of D-Dimers to Rule Out Venous Thromboembolism Events across Age Categories
por: Der Sahakian, G., et al.
Publicado: (2010)

D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism
por: Imberti, D.
Publicado: (2007)

Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism
por: Han, Donghee, et al.
Publicado: (2016)

Highly Elevated Quantitative D-Dimer Assay Values Increase the Likelihood of Venous Thromboembolism
por: Francis, Samuel, et al.
Publicado: (2019)

Decreased mean platelet volume in panic disorder
por: Göğçegöz Gül, Işıl, et al.
Publicado: (2014)

Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial
por: Kamachi, H., et al.
Publicado: (2020)

Humic Acids Inhibit Platelet Activation to Reduce Venous Thromboembolism in Mice
por: Lan, Hong-Tao, et al.
Publicado: (2022)

Venous thromboembolism in patients with COVID-19 and correlation with D-dimers: a single-centre experience
por: Khan, Muhammad Ziaullah, et al.
Publicado: (2020)

Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors()
por: Nauka, Peter C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qed6npgkaqpj038cl8j0u105eo